Immediate Impact
5 hit
Citing Papers
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
2021 Hit
The importance of exosomal PDL1 in tumour immune evasion
2020 Hit
Works of Hyerim Ha being referenced
Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy
2016
Therapeutic implication of HER2 in advanced biliary tract cancer
2016